Smith+Nephew plc (LON:SN, NYSE:SNN), the global medical technology company, announces that it will be attending the American Academy of Orthopaedic Surgeons (AAOS) 2024 Annual Meeting running from 12 to 16 February 2024 in San Francisco.
A number of commercial press releases are planned to coincide with AAOS, including:
· In Orthopaedics Reconstruction, confirmation of our leading robotic-assisted solutions for personalised orthopaedic surgery on show.
· In Trauma and Extremities, notification of the commercial launch of the AETOS◊ Shoulder System.
· In Sports Medicine, the premiere of our expanded biological healing portfolio, including the newly acquired CARTIHEAL AGILI-C◊ Cartilage Repair Implant alongside new applications for the REGENETEN◊ Bioinductive Implant.
In-line with prior years, Smith+Nephew will be hosting investors and financial analysts attending the show, including booth tours showcasing our products.
There will be no new information provided on current trading performance or financial targets at AAOS. Smith+Nephew will publish its Fourth Quarter and Full Year 2023 results on 27 February 2024.
